Eduardo M. Sotomayor, MD
Tampa General hospital recently announced the appointment of Eduardo M. Sotomayor, MD, as Director of its newly established Cancer Institute. A pioneer in the field of cancer immunology and immunotherapy and an expert in lymphoma research and treatment, Dr. Sotomayor will lead a team of Tampa General Hospital cancer specialists in the further development of the hospital’s cancer clinical care and clinical research services.
Dr. Sotomayor joins Tampa General Hospital from the George Washington University Cancer Center in Washington, DC, where he directed all cancer care and research activities during the past 5 years. His ongoing research in cancer
Richard Tuli, MD, PhD
immunology and immunotherapy focuses on developing novel, immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Previously, Dr. Sotomayor held leadership roles in some of the country’s nationally ranked cancer programs. He will work with radiation oncologist and researcher Richard Tuli, MD, PhD, who recently joined the team from Memorial Sloan Kettering Cancer Center.
‘Returning Back Home’
“I’m honored and thrilled to return back home to join the impressive and forward-thinking Tampa General team and look forward to building an innovative Cancer Institute together,” said Dr. Sotomayor. “Our priority is to use the latest research and therapies to provide the best care to patients in Florida and beyond, with special emphasis in breaking the barriers to access to cancer care to the community we serve.”
Through the Cancer Institute, Tampa General’s physicians will offer a highly coordinated range of multidisciplinary specialties such as hematologic malignancies; stem cell and cellular therapies; neuro-oncology; thoracic oncology; and breast, colorectal, and gynecologic oncology.
